Ursprung des Netzwerks ersten Grades von Matt Griffiths
| Einheit | Art der Einheit | Industrie | |
|---|---|---|---|
27
| Public Company | Pharmaceuticals: Major | 27 |
Unternehmensgrafik - zweiten Grades
Beziehungen zu mehreren Unternehmen
Unternehmensverbindungen über das persönliche Netzwerk von Matt Griffiths
| Unternehmen | Sektor | Verknüpfte Personen | Hauptposition |
|---|---|---|---|
| SCHOLAR ROCK HOLDING CORPORATION | Biotechnology | Chief Executive Officer Chief Tech/Sci/R&D Officer Director/Board Member Human Resources Officer | |
| AMGEN INC. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal Corporate Officer/Principal | |
| Massachusetts Institute of Technology | College/University | Undergraduate Degree Doctorate Degree Doctorate Degree | |
| TAKEDA PHARMACEUTICAL COMPANY LIMITED | Pharmaceuticals: Major | Comptroller/Controller/Auditor Corporate Officer/Principal | |
| DECIBEL THERAPEUTICS, INC. | Biotechnology | Chief Executive Officer Chief Operating Officer | |
| University of California, Berkeley | College/University | Doctorate Degree Undergraduate Degree | |
Millennium Pharmaceuticals, Inc.
 Millennium Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Millennium Pharmaceuticals, Inc. operates as a biopharmaceutical company. Its products include Ninlaro and Velcade. The company was founded in 1993 and is headquartered in Cambridge, MA. | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
Anadys Pharmaceuticals, Inc.
 Anadys Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Anadys Pharmaceuticals, Inc. develops and manufactures novel small molecule medicines. It engages in developing novel medicines in the areas of hepatitis C and oncology. The firm develops ANA598, a direct-acting antiviral for the treatment of hepatitis C. The company was founded by Stelios B. Papadopoulos and Kleanthis G. Xanthopoulos in 1992 and is headquartered in Little Falls, NJ. | Pharmaceuticals: Major | Chairman Director/Board Member | |
| MIT Sloan School of Management | College/University | Masters Business Admin Masters Business Admin | |
| ARRAY TECHNOLOGIES, INC. | Pharmaceuticals: Major | Founder Director/Board Member | |
| BIOVERATIV INC | Biotechnology | Corporate Officer/Principal Corporate Officer/Principal | |
| Georgetown University | College/University | Director/Board Member Doctorate Degree | |
| Stony Brook University | College/University | Undergraduate Degree Undergraduate Degree | |
| Rochester Christian University | College/University | Doctorate Degree Undergraduate Degree | |
Bain Capital Life Sciences LP
 Bain Capital Life Sciences LP Investment ManagersFinance Bain Capital Life Sciences LP (Bain Capital Life Sciences) is a private equity subsidiary of Bain Capital Private Equity LP, ultimately held by Bain Capital Holdings LP, founded in 2016. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Private Equity Investor Private Equity Investor | |
| CODIAK BIOSCIENCES | Pharmaceuticals: Major | Chief Executive Officer Corporate Officer/Principal | |
| SHIRE | Pharmaceuticals: Major | Corporate Officer/Principal Comptroller/Controller/Auditor | |
| OVID THERAPEUTICS INC. | Pharmaceuticals: Major | Director/Board Member President | |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Miscellaneous Commercial Services | Corporate Officer/Principal Director/Board Member | |
| University of Pennsylvania | College/University | Doctorate Degree Undergraduate Degree | |
Stablix, Inc.
 Stablix, Inc. Miscellaneous Commercial ServicesCommercial Services Stablix, Inc. is a biotechnology company based in New York, NY. The company is focused on establishing a new paradigm for tackling diverse diseases by harnessing the power of the body's own cellular machinery through targeted protein stabilization. Stablix's restored™ platform generates heterobifunctional small molecules (restoracs™) that selectively recruit active deubiquitinases (dubs) to target proteins for precise removal of ubiquitin to restore protein function. The company is currently advancing its lead programs towards clinical studies. The company's platform is based on the work of Henry Colecraft, Ph.D., professor of physiology and cellular biophysics, and professor of pharmacology, Columbia University Irving Medical Center. Stablix was founded in June 2021 with a $63 million series A led by founding investor Versant Ventures with New Enterprise Associates (NEA), Cormorant Asset Management, Euclidean Capital, and Alexandria Venture Investments. Stuart Anthony Kingsley has been the CEO of the company since 2022. | Miscellaneous Commercial Services | Chief Executive Officer Director/Board Member | |
| Tufts University School of Medicine | College/University | Doctorate Degree Doctorate Degree | |
| VISTERRA INC | Pharmaceuticals: Major | General Counsel Director/Board Member | |
| Harvard Business School | College/University | Masters Business Admin Masters Business Admin | |
Bioverativ Therapeutics, Inc.
 Bioverativ Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Bioverativ Therapeutics, Inc. develops pharmaceutical products. It develops medicines for chronic diseases such as hemophilia, anemia, multiple sclerosis, and autoimmune disorders. The company is headquartered in Cambridge, MA. | Pharmaceuticals: Major | President | |
| L’Institut de RYthmologie et Modélisation Cardiaque | Chairman | ||
| n-Lorem Foundation | Director/Board Member | ||
| Columbia University College of Physicians & Surgeons | College/University | Corporate Officer/Principal | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Chief Tech/Sci/R&D Officer | |
Revvity BV
 Revvity BV Medical SpecialtiesHealth Technology PerkinElmer focuses on improving the health and safety of people and the environment. The company is headquartered in Zaventem, Belgium. | Medical Specialties | Director/Board Member | |
| ZAI LAB LIMITED | Biotechnology | Director/Board Member | |
Carnegie Mellon University
 Carnegie Mellon University Other Consumer ServicesConsumer Services Carnegie Mellon University is an American school that operates as a college or university. It is located in Pittsburgh, Pennsylvania. | College/University | Doctorate Degree | |
National Investor Relations Institute
 National Investor Relations Institute Miscellaneous Commercial ServicesCommercial Services National Investor Relations Institute operates as an association of corporate officers and investor relations consultants responsible for communication among corporate management, shareholders, securities analysts and other financial community constituents. The company was founded by DeWitt C. Morrill in 1969 and is headquartered in Alexandria, VA. | Miscellaneous Commercial Services | Corporate Officer/Principal | |
| REVVITY, INC. | Medical Specialties | Director/Board Member | |
| Illinois Institute of Technology | College/University | Director/Board Member | |
| Society for Biological Engineering | Director/Board Member | ||
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal | |
Massachusetts Biotechnology Council
 Massachusetts Biotechnology Council Miscellaneous Commercial ServicesCommercial Services Massachusetts Biotechnology Council is a premier life sciences and healthcare hub with over 1,600 members dedicated to preventing, treating, and curing diseases through transformative science and technology. The non-profit company is based in Cambridge, MA. MassBio works to advance policy and promote education while providing member programs, events, industry information, and services. The company's mission is to advance Massachusetts' leadership in the life sciences to grow the industry, add value to the healthcare system, and improve patient lives. Founded in 1985 by James P. Sherblom, the CEO is Kendalle Burlin O'Connell. | Miscellaneous Commercial Services | Director/Board Member | |
| CSL LIMITED | Biotechnology | Chief Executive Officer | |
CSL Plasma, Inc.
 CSL Plasma, Inc. Medical/Nursing ServicesHealth Services CSL Plasma, Inc. collects donations of blood plasma in the U.S. through donation centers. The plasma is used by the company's parent to manufacture hemophilia therapies, burns, shock, infection, trauma, and breathing disorders. The company was founded in 2004 and is headquartered in Boca Raton, FL. | Medical/Nursing Services | Chief Operating Officer | |
CSL Behring LLC
 CSL Behring LLC BiotechnologyHealth Technology CSL Behring LLC researches, develops, manufactures, and markets biotherapies that are used to treat serious and rare conditions. It offers protein-based therapies in the areas of Bleeding Disorders, Fluid Replacement, Hereditary Angioedema, Immunoglobulin, Pulmonary, and Wound Healing Therapies. The company was founded in 2004 and is headquartered in King of Prussia, PA. | Biotechnology | Chief Executive Officer | |
| SERES THERAPEUTICS, INC. | Biotechnology | Investor Relations Contact | |
| Albert Einstein College of Medicine, Inc. | College/University | Corporate Officer/Principal | |
Biogen Idec, Inc. (North Carolina)
 Biogen Idec, Inc. (North Carolina) Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen Idec, Inc. (North Carolina) is a pharmaceutical company based in Durham, NC. The company develops pharmaceutical products. Michel Pericles Vounatsos has been the CEO of the company since 2016. | Pharmaceuticals: Major | Chief Executive Officer | |
Biogen GmbH
 Biogen GmbH Pharmaceuticals: MajorHealth Technology Part of Biogen, Inc., Biogen GmbH is a pioneer in the field of neuroscience since 1978. The company is based in Ismaning, Germany. Biogen focuses on research in therapeutic areas with a strong emphasis on difficult-to-treat diseases. The German company was founded in 1978 by Charles Weissman, Kenneth Murray, Heinz Schaller, Phillip Sharp, Walter Gilbert. The CEO is Michel Pericles Vounatsos. | Pharmaceuticals: Major | Chief Executive Officer | |
| BRISTOL-MYERS SQUIBB COMPANY | Pharmaceuticals: Major | Corporate Officer/Principal | |
| University of Michigan | College/University | Undergraduate Degree | |
| Kellogg School of Management | College/University | Masters Business Admin |
Statistik
International
| Vereinigte Staaten | 44 |
| Japan | 2 |
| Irland | 2 |
| Frankreich | 2 |
| Belgien | 2 |
Sektoral
| Health Technology | 26 |
| Consumer Services | 15 |
| Commercial Services | 6 |
| Finance | 3 |
| Health Services | 2 |
Operativ
| Director/Board Member | 105 |
| Corporate Officer/Principal | 65 |
| Undergraduate Degree | 27 |
| Independent Dir/Board Member | 23 |
| President | 22 |
Am stärksten vernetzte Beziehungen
| Insiders | |
|---|---|
| Steven Holtzman | 28 |
| Douglas Williams | 25 |
| Timothy Harris | 19 |
| Kevin Koch | 15 |
| Tony Kingsley | 14 |
| Douglas Kerr | 13 |
| Richard Brudnick | 13 |
| Amit Rakhit | 13 |
| Christian Schubert | 10 |
| Philip Ma | 10 |
| Paul McKenzie | 10 |
| Michel Vounatsos | 10 |
| John F. Weidenbruch | 9 |
| Jeffrey Sevigny | 9 |
| Kiran Reddy | 9 |
- Börse
- Insiders
- Matt Griffiths
- Unternehmensverbindungen
